Stacking
Currently, there is limited published research on combining retatrutide with other peptides or compounds. Given its comprehensive triple-receptor mechanism, retatrutide functions as a standalone therapy that simultaneously addresses multiple metabolic pathways.
Theoretical considerations for researchers:
With other GLP-1 agonists: Not recommended due to overlapping mechanisms and increased risk of gastrointestinal adverse events.
With metformin: Clinical trials included participants on stable metformin therapy; the combination appeared well-tolerated.
With lifestyle interventions: The clinical trials incorporated dietary counseling and physical activity guidance, which should be considered complementary rather than optional.